APA (7th ed.) Citation

Pfeiffenberger, J., Koschny, R., Hoffmann, K., Mehrabi, A., Schmitz, A., Radeleff, B., . . . Ganten, T. M. (2013). Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation. Langenbeck's archives of surgery, 398(8), . https://doi.org/10.1007/s00423-013-1114-1

Chicago Style (17th ed.) Citation

Pfeiffenberger, Jan, Ronald Koschny, Katrin Hoffmann, Arianeb Mehrabi, Anne Schmitz, Boris Radeleff, Wolfgang Stremmel, Peter Schemmer, and Tom M. Ganten. "Sorafenib Treatment Is Save and May Affect Survival of Recurrent Hepatocellular Carcinoma After Liver Transplantation." Langenbeck's Archives of Surgery 398, no. 8 (2013). https://doi.org/10.1007/s00423-013-1114-1.

MLA (9th ed.) Citation

Pfeiffenberger, Jan, et al. "Sorafenib Treatment Is Save and May Affect Survival of Recurrent Hepatocellular Carcinoma After Liver Transplantation." Langenbeck's Archives of Surgery, vol. 398, no. 8, 2013, https://doi.org/10.1007/s00423-013-1114-1.